Medicine
Dojolvi 0.96 g/mL oral liquid
Dojolvi 0.96 g/mL oral liquid is a prescription medicine containing Triheptanoin for oral use, marketed by Ultragenyx Pharmaceutical, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Do not freeze. Store at 20° to 25°C (68° to 77°F), excursions permitted to 15°…
Key facts
- Active ingredient (INN)
- Triheptanoin
- Brand
- Dojolvi
- Strength
- 0.96 g/mL
- Dosage form
- Oral liquid
- Route
- Oral
- Packs
- 1 bottle
- Marketing authorisation holder
- Ultragenyx Pharmaceutical
- Manufacturer
- Ultragenyx Pharmaceutical
- Origin register
- US FDA, United States
- Storage
- Do not freeze. Store at 20° to 25°C (68° to 77°F), excursions permitted to 15° to 30°C (59° to 86°F). Do not dose or store using materials made of polystyrene or polyvinyl chloride (PVC) containers.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 1 July 2020
- Identifiers
- RxCUI 2383555, 2383561DailyMed set ID 4cfeb8bd-143e-4dd7-bc34-b0bcda02460dNDC 69794-050Application NDA213687
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 bottle, glass in 1 carton / 500 mL in 1 bottle, glass | 69794-050-50 | Ultragenyx Pharmaceutical | 1 July 2020 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 30 June 2020 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Clinical summary
Triheptanoin is a medium-chain triglyceride indicated as a source of calories and fatty acids for the treatment of adult and pediatric patients with molecularly confirmed long-chain fatty acid oxidation disorders (LC-FAOD). It is available as oral liquid. MedsAcross supplies Triheptanoin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about TriheptanoinFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- DOJOLVI prescribing information (Ultragenyx Pharmaceutical) · U.S. National Library of Medicine, DailyMed
Need Dojolvi 0.96 g/mL oral liquid for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.